Agranulocytosis: Clinical Trials

59 trials for Agranulocytosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 9 not yet recruiting, 9 unknown, 5 recruiting. 59 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable59Completed 26, Not yet recruiting 9, Unknown 9, Recruiting 5, Terminated 5, Withdrawn 4, Active not recruiting 1

Follow Agranulocytosis: new trials by email Literature Review of Agranulocytosis trials Research Report on Agranulocytosis

Trials (filtered) newest first · largest first

All 59 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
G-CSF In Neonatal Sepsis With Neutropenia
Granulocyte-colony stimulating factor (G-CSF), Standard Sepsis Management - Neonatal Sepsis, Neutropenia
Not applicableNot yet recruitingUniversity of Health Sciences Lahore522027-02-152026-10-22
Diagnostic Accuracy, Clinical Utility and Implementation of Point-of-Care Absolute Neutrophil Count in Suspected Neutropenic Fever (DUCATIS) - Diagnostic Accuracy (S1)
Hemocue® WBC DIFF system - Suspected Neutropenic Fever, Confirmed Neutropenic Fever
Not applicableNot yet recruitingThe University of Hong Kong3172027-01-012026-10-28
Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia
Remote temperature monitoring device, Home temperature monitoring by a nurse - Oncopediatrics, Febrile Neutropenia
Not applicableNot yet recruitingCentre Hospitalier Universitaire de la Réunion302026-12-012026-10-23
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Acupuncture - Febrile Neutropenia, Sarcoma
Not applicableNot yet recruitingShaare Zedek Medical Center602026-12-012026-04-29
Effects of Resistance Training on Recovery During Hematopoietic Stem Cell Transplantation
8-week Elastic Band Resistance Training Program - Hematologic Malignancies, Hematopoietic Stem Cell Transplantation
Not applicableNot yet recruitingTaipei Veterans General Hospital, Taiwan862026-10-122026-10-14
Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
Clinical Stability-Driven Antibiotic Discontinuation Strategy, Standard of Care Antibiotic Duration - Bloodstream Infection, Gram Negative Infections
Not applicableRecruitingValeria Cento1722026-02-022026-09-24
Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever
Early antibiotic cessation alert - Leukemia, CART Therapy
Not applicableRecruitingPeter MacCallum Cancer Centre, Australia2142025-12-032025-12-15
ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
Alio Smart Patch™ - Febrile Neutropenia
Not applicableCompletedCase Comprehensive Cancer Center352025-08-062026-07-24
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
Empirical treatment - Carbapenem-resistant Enterobacterales, Neutropenia
Not applicableNot yet recruitingShanghai Jiao Tong University School of Medicine912025-08-012025-07-02
Pharmacist-Led Education to Improve Neutropenic Precautions in Cancer Patients
Pharmacist-Led Neutropenic Education Package - Febrile Neutropenia
Not applicableActive not recruitingJordan University of Science and Technology3002025-07-132026-07-08
A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients
sulpegfilgrastim - Multiple Myeloma, DRD
Not applicableNot yet recruitingThe First Affiliated Hospital of Soochow University242025-06-302025-06-12
Human Bioequivalence Study of Liposomal Amphotericin B for Injection
Test product (Liposomal amphotericin B for injection, Sichuan Huiyu Pharmaceutical Co., Ltd.), Reference product (AmBisome®, Astellas Pharma US Inc.) - Invasive Fungal Infections, Neutropenic Fever
Not applicableCompletedSichuan Huiyu Pharmaceutical Co., Ltd582025-05-252026-05-27
Human Bioequivalence Study of Amphotericin B Liposome for Injection
Amphotericin B Liposome for Injection (strength: 50 mg, Sichuan Huiyu Pharmaceutical Co., Ltd.), Amphotericin B Liposome for Injection (trade name: Ambisome®, strength: 50 mg, MAH: Gilead Sciences) - Invasive Fungal Infections, Neutropenic Fever
Not applicableCompletedSichuan Huiyu Pharmaceutical Co., Ltd422025-05-132026-05-22
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
Loratadine, Diosmin-Hesperidin, Loratadine + Diosmin-Hesperidin - Hematologic Malignancy, Neutropenia
Not applicableRecruitingAlexandria University882025-03-012026-06-24
Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial)
NF Protocol, ASTERIC protocol, ASTERIC Protocol - Neutropenic Fever
Not applicableNot yet recruitingThe University of Hong Kong6482025-02-012025-01-27
Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients
Automated fever alerts - Pediatric Oncology Patients With Risk for Infections
Not applicableRecruitingInsel Gruppe AG, University Hospital Bern2502025-02-012026-10-22
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
PRIOR [Proactive Intensive Oral Review & Treatment] - Oncology, Periodontitis
Not applicableNot yet recruitingUniversity of Leeds602024-07-012024-06-10
Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic Patients
Metagenomic diagnosis (mNGS, DISQVER) - Immunodepressed Patients (Hemato-oncology)
Not applicableTerminatedPoitiers University Hospital1842024-01-122026-08-25
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
Ceftolozane/tazobactam, Piperacillin/tazobactam - Hematologic Neoplasms, Neutropenia
Not applicableUnknownInstituto Nacional de Cancerologia de Mexico2262023-11-072024-06-04
Mucorales PCR Screening in At-risk Hematology Patients
Mucorales PCR (MucorGenius, PathoNostics, Maastricht, The Netherlands) - Mucormycosis
Not applicableCompletedUniversitaire Ziekenhuizen KU Leuven2002023-11-062026-10-23

Showing 20 of 59. Sign in to see all of them.

Narrower conditions

Neutropenia (33)  ·  Febrile Neutropenia (30)  ·  Fever (10)  ·  Neoplasms (10)  ·  Hematologic Neoplasms (9)  ·  Infections (5)  ·  Invasive Fungal Infections (5)  ·  Leukemia (5)  ·  Sepsis (4)  ·  Thrombocytopenia (4)  ·  Leukemia, Myeloid, Acute (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Anemia (2)  ·  Burkitt Lymphoma (2)  ·  Chemotherapy-Induced Febrile Neutropenia (2)

Broader conditions

Hemic and Lymphatic Diseases (59)  ·  Leukocyte Disorders (59)  ·  Hematologic Diseases (58)  ·  Leukopenia (58)  ·  Cytopenia (57)  ·  Neutropenia (26)  ·  Neoplasms (19)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Neoplasms by Site (14)  ·  Infections (13)  ·  Pathologic Processes (13)  ·  Neoplasms by Histologic Type (12)  ·  Body Temperature Changes (10)  ·  Signs and Symptoms (10)

Interventions

Piperacillin, Tazobactam Drug Combination (3)  ·  Caspofungin (2)  ·  Injections (2)  ·  Long-Term Synaptic Depression (2)  ·  Acupuncture Therapy (1)  ·  Algorithms (1)  ·  Amikacin (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Amphotericin B (1)  ·  Anti-Infective Agents (1)  ·  Antilymphocyte Serum (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Ciprofloxacin (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  Chinese PLA General Hospital (2)  ·  Peter MacCallum Cancer Centre, Australia (2)  ·  Shanghai Jiao Tong University School of Medicine (2)  ·  Sichuan Huiyu Pharmaceutical Co., Ltd (2)  ·  The University of Hong Kong (2)  ·  Alexandria University (1)  ·  Augusta University (1)  ·  Case Comprehensive Cancer Center (1)  ·  Centre Hospitalier Universitaire de la Réunion (1)  ·  Ciusss de L'Est de l'Île de Montréal (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  DERSHENG SUN (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)

Countries

United States (10)  ·  China (7)  ·  France (7)  ·  Belgium (3)  ·  Israel (3)  ·  Italy (3)  ·  Switzerland (3)  ·  Australia (2)  ·  Brazil (2)  ·  Canada (2)  ·  Germany (2)  ·  Hong Kong (2)  ·  United Kingdom (2)  ·  Denmark (1)  ·  Egypt (1)

Top investigators

Qing Wen (2)  ·  Abby P Douglas, MBBS PhD FRACP (1)  ·  Abd Al-Rahman AR Awad, PharmD (1)  ·  Bushra Fatima (1)  ·  Dafna Yahav, MD (1)  ·  Dolores Grosso, DNP, CRNP (1)  ·  Eva K Brack, MD, PhD (1)  ·  Gabriel A Brooks, MD (1)  ·  Han-Wei Su (1)  ·  Henrique NS Bittencourt, PhD (1)  ·  Jiong Hu (1)

Results publications

PMID 10091805, PMID 17008536, PMID 17573453, PMID 18322708, PMID 18619375, PMID 20953908, PMID 22050904, PMID 22461866, PMID 22776268, PMID 23358983, PMID 23485478, PMID 23954992, PMID 24179471, PMID 25299140, PMID 25386344, PMID 25445023, PMID 25728366, PMID 26061092, PMID 26169616, PMID 26345187, PMID 26473759, PMID 27456299, PMID 28042020, PMID 28061985, PMID 28073680, PMID 28253393, PMID 28458705, PMID 28514979, PMID 28621019, PMID 28670114, PMID 28688533, PMID 28842786, PMID 28915856, PMID 29171820, PMID 29313949, PMID 29336645, PMID 29506345, PMID 29626261, PMID 30165140, PMID 30191843, PMID 30461314, PMID 30725636, PMID 30825389, PMID 31302766, PMID 31541205, PMID 31626055, PMID 31818338, PMID 31879764, PMID 32058362, PMID 32132841

NIH funding

UG1CA189974 (1)